Evaluation of factors affecting the duration of disease-modifying anti-rheumatic drugs application in patients with enthesitis-related arthritis.

MLA

Kısaarslan, Ayşenur Paç, et al. “Evaluation of Factors Affecting the Duration of Disease-Modifying Anti-Rheumatic Drugs Application in Patients with Enthesitis-Related Arthritis.” European Journal of Rheumatology, vol. 6, no. 3, Apr. 2019, pp. 130–35. EBSCOhost, https://doi.org/10.5152/eurjrheum.2019.18180.

APA

Kısaarslan, A. P., Sözeri, B., Gündüz, Z., Zararsız, G., Poyrazoğlu, H., & Düşünsel, R. (2019). Evaluation of factors affecting the duration of disease-modifying anti-rheumatic drugs application in patients with enthesitis-related arthritis. European Journal of Rheumatology, 6(3), 130–135. https://doi.org/10.5152/eurjrheum.2019.18180

Chicago

Kısaarslan, Ayşenur Paç, Betül Sözeri, Zübeyde Gündüz, Gökmen Zararsız, Hakan Poyrazoğlu, and Ruhan Düşünsel. 2019. “Evaluation of Factors Affecting the Duration of Disease-Modifying Anti-Rheumatic Drugs Application in Patients with Enthesitis-Related Arthritis.” European Journal of Rheumatology 6 (3): 130–35. doi:10.5152/eurjrheum.2019.18180.